Kingfa Science & Technology (India) Ltd
Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves. [1]
- Market Cap ₹ 3,425 Cr.
- Current Price ₹ 2,835
- High / Low ₹ 3,734 / 1,400
- Stock P/E 25.5
- Book Value ₹ 539
- Dividend Yield 0.35 %
- ROCE 30.1 %
- ROE 23.2 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 45.1% CAGR over last 5 years
- Company's median sales growth is 23.0% of last 10 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Plastic products Industry: Plastics Products
Part of BSE Allcap BSE Industrials BSE SmallCap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
157 | 178 | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1,048 | 1,404 | 1,488 | 1,633 | |
155 | 181 | 212 | 288 | 408 | 560 | 666 | 698 | 607 | 966 | 1,276 | 1,303 | 1,431 | |
Operating Profit | 2 | -3 | 6 | 27 | 19 | 41 | 35 | 43 | 20 | 82 | 128 | 185 | 202 |
OPM % | 1% | -2% | 3% | 8% | 5% | 7% | 5% | 6% | 3% | 8% | 9% | 12% | 12% |
1 | 0 | 0 | 1 | 4 | 6 | 4 | 3 | 6 | -22 | 2 | 3 | 5 | |
Interest | 7 | 7 | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 6 |
Depreciation | 3 | 3 | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 21 |
Profit before tax | -7 | -12 | -5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 180 |
Tax % | -29% | -31% | -35% | 38% | 30% | 36% | 35% | 26% | 55% | 26% | 26% | 25% | |
-5 | -8 | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 134 | |
EPS in Rs | -4.14 | -6.95 | -2.49 | 8.93 | 10.24 | 20.35 | 15.74 | 20.33 | 4.39 | 25.29 | 67.22 | 101.17 | 110.82 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | 24% |
5 Years: | 16% |
3 Years: | 33% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | 32% |
5 Years: | 45% |
3 Years: | 185% |
TTM: | 10% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 36% |
3 Years: | 46% |
1 Year: | 29% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 14% |
3 Years: | 19% |
Last Year: | 23% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 10 | 10 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Reserves | 13 | 5 | 2 | 109 | 234 | 293 | 312 | 336 | 342 | 372 | 454 | 576 | 641 |
34 | 62 | 75 | 16 | 42 | 21 | 17 | 46 | 71 | 46 | 42 | 33 | 46 | |
31 | 31 | 41 | 95 | 119 | 159 | 210 | 202 | 246 | 449 | 502 | 373 | 364 | |
Total Liabilities | 85 | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,063 |
26 | 24 | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 245 | |
CWIP | 0 | 0 | 1 | 41 | 10 | 2 | 79 | 115 | 123 | 127 | 131 | 2 | 10 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
58 | 81 | 99 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 808 | |
Total Assets | 85 | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,063 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | -24 | -1 | 19 | -119 | -116 | 96 | 30 | -2 | 38 | 27 | 16 | |
2 | -1 | -4 | -47 | -18 | -6 | -77 | -63 | -14 | -19 | -12 | -5 | |
-11 | 25 | 5 | 34 | 137 | 14 | -7 | 22 | 17 | -14 | -21 | -8 | |
Net Cash Flow | 0 | 0 | 0 | 6 | -1 | -108 | 12 | -11 | 1 | 5 | -6 | 3 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 78 | 97 | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 |
Inventory Days | 52 | 54 | 64 | 85 | 69 | 85 | 63 | 67 | 100 | 110 | 94 | 76 |
Days Payable | 68 | 66 | 72 | 127 | 108 | 108 | 119 | 115 | 152 | 181 | 155 | 110 |
Cash Conversion Cycle | 62 | 85 | 85 | 57 | 72 | 86 | 53 | 49 | 71 | 28 | 32 | 66 |
Working Capital Days | 57 | 90 | 87 | 66 | 82 | 99 | 59 | 69 | 82 | 48 | 56 | 86 |
ROCE % | -1% | -9% | 4% | 22% | 9% | 13% | 9% | 10% | 4% | 16% | 25% | 30% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 30 Oct
- Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Oct
-
Performance Update For The Half Year Ended September 30, 2024
29 Oct - Performance update for H1 FY 2024-25.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 Oct - Appointment of CTO and Tax Auditor approved.
- Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024 29 Oct
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio
The Co.’s products include Modified Polypropylene Compound, Engineering Plastic Compound, and Personal Protective Equipment (PPE) like Mask and Gloves. [1] The PPE division added new lines for 3 Ply, foldable masks, and facilities for different variants. [2]